Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bovine nasal swabs viral metagenome

ABSTRACT: Bovine nasal swabs viral metagenome Raw sequence reads

PROVIDER: PRJNA634678 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11836800_1.fastq.gz	Fastqsanger.gz
	SRR11836900_1.fastq.gz	Fastqsanger.gz
	SRR11837000_1.fastq.gz	Fastqsanger.gz
	SRR11836801_1.fastq.gz	Fastqsanger.gz
	SRR11836901_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 310

Similar Datasets

Nasal swabs

Project description:Nasal swabs Raw sequence reads

| PRJNA998709 | ENA

bovine metagenome

Project description:Bovine Nasal Swabs Metagenome

| PRJNA273738 | ENA

Cattle nasal and rectal swabs metagenome

Project description:Cattle nasal and rectal swabs samples metagenome raw sequence reads

| PRJNA1120236 | ENA

Nasal swabs and co-cultured samples

Project description:Nasal swabs and co-cultured samples Raw sequence reads

| PRJNA550035 | ENA

Therapy of allergic rhinitis using ribavirin spray to clear nasal commensal viruses

Project description:For analyzing the exploratory nasal commensal viruses, we performed the metatranscriptomic analysis of the nose swabs from the enrolled AR patients both before and after treatments, as well as sequenced the nose swabs from a set of healthy volunteers without AR history.Simultaneously, to assess the expression of interferon-stimulated genes in patients with allergic rhinitis, we analyzed the gene expression of host reads.

2024-08-21 | GSE275114 | GEO

Detection of SARS-CoV-2 in nasal swabs using MALDI-MS

Project description:Detection of SARS-CoV-2 using RT–PCR and other advanced methods can achieve high accuracy. However, their application is limited in countries that lack sufficient resources to handle large-scale testing during the COVID-19 pandemic. Here, we describe a method to detect SARS-CoV-2 in nasal swabs using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and machine learning analysis. This approach uses equipment and expertise commonly found in clinical laboratories in developing countries. We obtained mass spectra from a total of 362 samples (211 SARS-CoV-2-positive and 151 negative by RT–PCR) without prior sample preparation from three different laboratories. We tested two feature selection methods and six machine learning approaches to identify the top performing analysis approaches and determine the accuracy of SARS-CoV-2 detection. The support vector machine model provided the highest accuracy (93.9%), with 7% false positives and 5% false negatives. Our results suggest that MALDI-MS and machine learning analysis can be used to reliably detect SARS-CoV-2 in nasal swab samples.

2020-09-11 | PXD021388 | Pride

Piglet nasal swabs

Project description:Piglet nasal microbiota

| PRJNA687981 | ENA

bovine viral diarrhea virus

Project description:bovine viral diarrhea virus Raw sequence reads

| PRJNA932184 | ENA

A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood

Project description:To elucidate key pathways in the host transcriptome of patients infected with SARS-CoV-2, we used RNA sequencing (RNA Seq) to analyze nasopharyngeal (NP) swab and whole blood (WB) samples from 333 COVID-19 patients and controls, including patients with other viral and bacterial infections. Analyses of differentially expressed genes (DEGs) and pathways was performed relative to other infections (e.g. influenza, other seasonal coronaviruses, bacterial sepsis) in both NP swabs and WB. Comparative COVID-19 host responses between NP swabs and WB were examined. Both hospitalized patients and outpatients exhibited upregulation of interferon-associated pathways, although heightened and more robust inflammatory and immune responses were observed in hospitalized patients with more clinically severe disease. A two-layer machine learning-based classifier, run on an independent test set of NP swab samples, was able to discriminate between COVID-19 and non-COVID-19 infectious or non-infectious acute respiratory illness using complete (>1,000 genes), medium (<100) and small (<20) gene biomarker panels with 85.1%-86.5% accuracy, respectively. These findings demonstrate that SARS-CoV-2 infection has a distinct biosignature that differs between NP swabs and WB and can be leveraged for differential diagnosis of COVID-19 disease.

2020-12-15 | GSE163151 | GEO

Bovine nasal, ruminal, and vaginal microbiota

Project description:Bovine nasal, ruminal, and vaginal microbiota

| PRJNA721423 | ENA